Northern Trust’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-666,180
| Closed | -$14.3M | – | 4472 |
|
|
2026
Q1 | $14.3M | Buy |
666,180
+49,145
| +8% | +$692K | ﹤0.01% | 1877 |
|
|
2025
Q4 | $5.75M | Sell |
617,035
-12,557
| -2% | -$105K | ﹤0.01% | 2389 |
|
|
2025
Q3 | $4.44M | Buy |
629,592
+18,431
| +3% | +$127K | ﹤0.01% | 2568 |
|
|
2025
Q2 | $3.97M | Buy |
611,161
+75,164
| +14% | +$517K | ﹤0.01% | 2593 |
|
|
2025
Q1 | $4.25M | Sell |
535,997
-11,053
| -2% | -$119K | ﹤0.01% | 2507 |
|
|
2024
Q4 | $6.93M | Buy |
547,050
+51,960
| +10% | +$723K | ﹤0.01% | 2330 |
|
|
2024
Q3 | $6.9M | Sell |
495,090
-37,949
| -7% | -$541K | ﹤0.01% | 2290 |
|
|
2024
Q2 | $7.35M | Sell |
533,039
-25,106
| -4% | -$367K | ﹤0.01% | 2177 |
|
|
2024
Q1 | $9.22M | Sell |
558,145
-18,607
| -3% | -$278K | ﹤0.01% | 2086 |
|
|
2023
Q4 | $8.42M | Buy |
576,752
+24,898
| +5% | +$302K | ﹤0.01% | 2177 |
|
|
2023
Q3 | $6.77M | Buy |
551,854
+119,262
| +28% | +$1.56M | ﹤0.01% | 2256 |
|
|
2023
Q2 | $5.17M | Buy |
432,592
+213,071
| +97% | +$2.78M | ﹤0.01% | 2479 |
|
|
2023
Q1 | $2.93M | Sell |
219,521
-5,748
| -3% | -$112K | ﹤0.01% | 2763 |
|
|
2022
Q4 | $4.85M | Buy |
225,269
+219
| +0.1% | +$4.49K | ﹤0.01% | 2509 |
|
|
2022
Q3 | $4.51M | Buy |
225,050
+34,540
| +18% | +$735K | ﹤0.01% | 2554 |
|
|
2022
Q2 | $3.41M | Buy |
190,510
+20,211
| +12% | +$209K | ﹤0.01% | 2756 |
|
|
2022
Q1 | $1.69M | Buy |
170,299
+66,622
| +64% | +$880K | ﹤0.01% | 3179 |
|
|
2021
Q4 | $1.75M | Buy |
103,677
+5,578
| +6% | +$115K | ﹤0.01% | 3288 |
|
|
2021
Q3 | $2.33M | Buy |
98,099
+85,381
| +671% | +$2.05M | ﹤0.01% | 3208 |
|
|
2021
Q2 | $290K | Buy |
+12,718
| New | +$265K | ﹤0.01% | 3956 |
|
Other funds holding DAWN
Northern Trust's DAWN Position: Q2 2026 in Review
Northern Trust sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 666,180 shares — an estimated $14.3M sold.
Northern Trust first reported a position in DAWN in Q2 2021 and held it in 20 quarters. The position peaked at $14.3M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- Northern Trust reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Northern Trust sold 666,180 Day One Biopharmaceuticals shares in Q2 2026, an estimated $14.3M.
- Northern Trust first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 20 quarters.
- Northern Trust's Day One Biopharmaceuticals position peaked at $14.3M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.